Showing results (1591-1600 of 6,509) with videos related to

Sort By:
Pageof 651
Cancer Immunology, Immunotherapy : CII|July 14, 2026
Pilot report of an anti-PD-1/VEGF bispecific antibody for treating recurrent H3K27M-mutant diffuse midline gliomasLi Yanchu, Wang Hongbin, Yuan Xiaoli, et al.
Cancer Immunology, Immunotherapy : CII|April 15, 2026
Promoting APC function of B cells via reprogramming the fatty acid metabolism enhances anticancer immunity in metastatic ovarian cancerHaoke Zhang, Chunyan Yu, Wei Du, et al.
Cancer Immunology, Immunotherapy : CII|April 15, 2026
Targeting Blimp-1 in T cells results in activation of T-bet-mediated control of immunosuppression in lung cancerSusetta Finotto, Mircea T Chiriac, Susanne Krammer, et al.
Cancer Immunology, Immunotherapy : CII|April 2, 2026
Integrated spatial transcriptomics and pan-cancer XGBoost modeling uncover spatial drivers of immune exclusion and predict immunotherapy responseHongying Zhao, Wangyang Liu, Haotian Xu, et al.
Cancer Immunology, Immunotherapy : CII|May 4, 2026
Rosuvastatin enhances the efficacy of venetoclax-azacitidine in older acute myeloid leukemia patients via reducing T-cell exhaustionYuanmei Zhai, Yehua Yu, Renjun Bao, et al.
Cancer Immunology, Immunotherapy : CII|April 21, 2026
Repurposing public sarcoma multi-omics for neoantigen discoveryPanagiotis Mantas, Karen A Krogfelt
Cancer Immunology, Immunotherapy : CII|April 21, 2026
IL-18-armed oncolytic vaccinia virus remodels the suppressive microenvironment via macrophage and Treg modulation in lymphomaHui Wu, Jiaqing Zhang, Li Xu, et al.
Cancer Immunology, Immunotherapy : CII|April 21, 2026
Envafolimab combined with lenvatinib and albumin-bound paclitaxel in previously treated advanced gastric/gastroesophageal junction (G/GEJ) adenocarcinoma: a prospective, phase II, multi-cohort trialZhao Xiaoying, Feng Wanjing, Geng Qirong, et al.
Cancer Immunology, Immunotherapy : CII|March 24, 2026
Immunological effects of amivantamab in EGFR or MET-expressing non-small cell lung cancerRyo Yoshichika, Fumiaki Mukohara, Kotaro Yamada, et al.
Cancer Immunology, Immunotherapy : CII|April 15, 2026
Hematological toxicities and thrombosis risk associated with immune checkpoint inhibitors: a pharmacovigilance study from 2014 to 2024Jingyi Hou, Guangyan Mu, Zhuo Zhang, et al.
Pageof 651